Social Investments

We believe we have an important role and responsibility in improving access to medicines, vaccines and quality health care, and helping to address barriers to care worldwide.

Our company and Foundation support innovative programs and partnerships to improve the health and wellbeing of people around the world. Through these programs, we believe that by working closely with othersgovernments, donors, patient groups, health care professionals, nongovernmental organizations (NGOs), academic institutions, multilateral agencies and the private sectorwe can help strengthen health systems and improve population health outcomes.

The programs highlighted below are examples of our ongoing social investments:

ACS: global patient navigation

Through a ~$2 million grant over five years (2019–2023), our company’s Foundation is helping the American Cancer Society (ACS) bring its expertise in patient navigation to countries with a growing burden of cancer. This partnership aims to improve access to cancer care in sub-Saharan Africa and develop guidance to help low- and middle-income countries adopt comprehensive models of care.

Addressing the opioid crisis in West Virginia

Our company’s Foundation is supporting Marshall Health through a $2 million grant over four years (2018–2021) to establish a comprehensive program to address the opioid crisis in West Virginia.

Alliance to Advance Patient-Centered Cancer Care

With a $15 million, five-year (2017-2021) commitment from our company’s Foundation, the Alliance to Advance Patient-Centered Cancer Care aims to increase timely access to patient-centered care and reduce disparities in cancer care, especially for vulnerable and underserved populations in the United States.

Bridging the Gap: Reducing Disparities in Diabetes Care

With a $16 million, five-year (2017-2021) commitment from our company’s Foundation, Bridging the Gap: Reducing Disparities in Diabetes Care  is working to improve access to high-quality diabetes care and to reduce health disparities among vulnerable and underserved populations with type 2 diabetes in the United States.

HIV Care Connect

With a $7 million, five-year (2019-2023) commitment from our company’s Foundation, HIV Care Connect aims to reduce disparities in access to care and improve health outcomes for people of color living with HIV in vulnerable and underserved communities in the Southeastern United States.

Improving Alzheimer’s care in the U.S.

Through a $3 million, four-year (2018-2021) commitment from our company’s Foundation, we are supporting the Alzheimer’s Association, Massachusetts/New Hampshire Chapter and HealthPartners Center for Memory and Aging in their efforts to improve the coordination of high-quality care for people living with Alzheimer’s and their caregivers.

MECTIZAN® Donation Program

The MECTIZAN® (ivermectin) Donation Program is the longest-running disease-specific drug donation program and public-private partnership of its kind and is widely regarded as one of the most successful public-private health collaborations in the world.

MSD Medical Outreach Program (MMOP)

Our company’s Medical Outreach Program was established in 1958. It is the primary mechanism through which our company donates its pharmaceuticals and vaccines for humanitarian assistance in the developing world and in support of disaster relief and emergency situations worldwide.

MSD Fellowship for Global Health

The MSD Fellowship for Global Health is a three-month, immersive corporate pro bono program to contribute the skills and talents of our employees to help build the capacity of NGOs dedicated to improving health around the world.

MSD for Mothers

MSD for Mothers is a 10-year, $500 million initiative focused on improving the health and wellbeing of mothers before, during and after pregnancy and childbirth. Working together with committed partners, we believe we can help make pregnancy and childbirth a safe, healthy and joyful experience for women.

University of New Mexico Health Sciences Center

To help build health care capacity and expand access to specialty care for complex and chronic conditions among underserved populations in Asia, our company’s Foundation provided a $7 million grant over five years (2017-2021) to the University of New Mexico Health Sciences Center to support the replication of their telementoring program  in India and Vietnam.

The ONE Campaign – (RED)

Our company provided a ~$1 million grant to The ONE Campaign, the parent organization of (RED), to support Paint (RED) Save Lives – a global street art campaign to raise awareness about HIV/AIDS in support of the sixth replenishment of The Global Fund in October 2019. Building on this partnership, we have committed ~$1.2 million over two years (2020-2021) to support (RED)’s key awareness campaigns to bring attention to the global HIV/AIDS crisis and the need to fund The Global Fund’s efforts to end the HIV epidemic.

University of North Carolina (UNC) Gillings School of Global Public Health – diabetes peer support program in Shanghai, China

Our company’s Foundation provided a ~$886,000, five year (2016–2020) grant to the UNC Gillings School of Global Public Health to support the development, implementation and evaluation of a diabetes peer support program in nine community health centers (CHCs) in Shanghai, China and to facilitate dissemination of the resulting model across the city’s 240 CHCs.

U.S. patient assistance programs

More than 55 years ago, our company created our first U.S. patient assistance program (PAP) to keep affordable medicines within patients’ reach. Today, our patient assistance offerings include several programs.

The trademarks used herein are owned by their respective owners.